Induction of cardiac fibrosis by aldosterone

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 6, 2000, Pages 865-879

  Lijnen, Paul ^a   Petrov, Victor ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

Author keywords

Aldosterone; Cardiac fibrosis; Collagen; Fibroblasts

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOCORTICOID; MINERALOCORTICOID RECEPTOR;

ENZYME INHIBITION; FIBROBLAST; FIBROGENESIS; HEART MUSCLE FIBROSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

DIGITALIS;

EID: 0033840926     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1129     Document Type: Article

References (114)

1. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin angiotensin aldosterone system
2. Similarity between a substance produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone
3. Myocardial production of aldosterone and corticosterone in the rat
4. Aldosterone and the heart: Towards a physiological function?
5. Steroid hormones and the cardio-vascular system: Direct action of estradiol, progesterone, testosterone, gluco- and mineralocorticoids, and soltriol (vitamin D) on central nervous regulatory and peripheral tissues
6. Prerequisite for cardiac aldosterone action
7. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor
8. High affinity aldosterone binding sites I receptors in rat heart
9. Detection of corticosteroid type 1 binding sites in heart
10. Purification and characterization of the activated mineralocorticoid receptor from rat myocardium
11. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor
12. Type I and type II corticosteroid receptor gene expression in the rat: Effect of adrenalectomy and dexamethasone administration
13. Angiotensin II and aldosterone receptor binding in rat heart and kidney: Response to chronic angiotensin II or aldosterone administration
14. High glucose stimulates aldosterone-induced hypertrophy in type I mineralocorticoid receptors in neonatal rat cardiomyocytes
15. Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta
16. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts?
17. Aldosterone: Intracellular receptors in human heart
18. Inhibition of hepatic fibrogenesis. A review of pharmacologic candidates
19. Progesterone binding to mineralocorticoid receptors in vitro and in vivo studies
20. Glucocorticoid metabolism in the cardiac interstitium: 11β-hydroxysteroid dehydrogenase activity in cardiac fibroblasts
21. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
22. Role of extracellular matrix proteins in heart function
23. 2 chains of type IV collagen in the infarct zone of rat myocardial infarction
24. Relation of structure to function of the tissues of the wall of blood vessels
25. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium
26. Collagen: Scaffold for repair and execution
27. Monitoring fibrillar collagen turnover in hypertensive heart disease
28. Circulating C-terminal propeptide of type I procollagen is cleared mainly via a mannose receptor in the liver endothelial cells
29. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver
30. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis
31. The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction
32. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction
33. Collagen scar formation after acute myocardial infarction
34. Radioimmunoassay for the pyridoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
35. Connective tissue and repair in the heart
36. Connective tissue: Metabolic entity?
37. Inflammatory and vascular basis of connective tissue disease
38. Myofibroblasts from diverse pathologic settings in their content of actin isoforms and intermediate filament proteins
39. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion
40. Bradykinin receptor and tissue ACE binding in myo-cardial fibrosis: Response to chronic angiotensin II or aldosterone administration in rats
41. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis
42. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction
43. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of fenotypic modulation
44. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing
45. The α-smooth muscle actin-positive cells in healing human myocardial scars
46. Contractile cells in rat myocardial scar tissue
47. Dupuytren's contracture: Fibroblast contraction
48. Granulation tissue as a contractile organ. A study of structure and function
49. Phenotypic and functional features of myofibroblasts in sheep fetal wounds
50. 1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
51. 1 in quiescent human breast gland neoplasia
52. Rat alveolar myofibroblasts asquire α-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis
53. Myofibroblasts and their role in lung collagen expression during pulmonary fibrosis: A combined immunohistochemical and in situ hybridization
54. Aldosterone and cardiac fibrosis: In vitro studies
55. Stimulation of collagen secretion by angiotensin II and transforming growth factor-β in rat cardiac fibroblasts
56. Effect of angiotensin II and transforming growth factorβ on collagen secretion in cardiac fibroblasts
57. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
58. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts
59. Extra-adrenal mineralocorticoids and cardiovascular tissue
60. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone
61. Mineralocorticoids, hypertension and cardiac fibrosis
62. Reactive and reparative myocardial fibrosis in arterial hyper-tension in the rat
63. Antifibrotic effect of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
64. Myocardial fibrosis associated with aldosterone or angiotensin II administration. Attenuation by calcium channel blockade
65. Transforming growth factor β-induced collagen synthesis during calcium channel blockade in cardiac fibroblasts
66. Mineralocorticoid excess, dietary sodium and myocardial fibrosis
67. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats
68. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells
69. Determinants of cardiac fibrosis in experimental hyper-mineralocorticoid states
70. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension
71. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride
72. The production of cardiac lesions by repeated injections of desoxycorticosterone acetate
73. Cardioreparation and the concept of modulating cardiovascular structure and function
74. In vivo left ventricular function and collagen expression in aldosterone/salt hypertension
75. Remodeling of the rat right and left ventricles in experimental hypertension
76. Biological determinants of aldosterone-induced cardiac fibrosis in rats
77. Expression and accumulation of interstitial collagen in the neonatal rat heart
78. The renin-angiotensin system in experimental mineralo-corticoid-salt-induced cardiac fibrosis
79. Transforming growth factor beta-1 in acute myocardial infarction in rats
80. Colocalization of myocardial fibrosis and inflammatory cells in rats
81. 1 receptor subtype as a cardiac target of aldosterone. Role in aldosterone-salt induced fibrosis
82. Effect of aldosterone on vascular angiotensin II receptors in the rat
83. Angiotensin II stimulates the autocrine production of transforming growth factor β-1 in adult rat cardiac fibroblasts
84. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat
85. Cultured myofibro-blasts generate angiotensin peptides de novo
86. Transforming growth factor β-induced differentiation of cardiac fibroblasts to myofibroblasts is accompanied by an increase in angiotensin converting enzyme activity
87. 1 induces angiotensin converting enzyme synthesis in rat cardiac fibroblasts during differentiation to myofibro-blasts. Submitted for publication to
88. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: Response to chronic angiotensin II or aldosterone administration in rats
89. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts
90. Angiotensin II-induced myocardial fibrosis in rats: Role of nitric oxide, prostaglandins and bradykinin
91. Antagonism of the renin-angiotensin-aldosterone system and collagen in cardiac fibroblasts
92. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes
93. Aldosterone regulates collagen output of rat cardiac fibroblasts by upregulation of endothelin receptors
94. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy
95. Left ventricular hypertrophy and its regression: Pathophysiology and therapeutic approach
96. Aldosterone affects left ventricular structure and function in essential hypertension
97. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
98. Left ventricular hypertrophy in asymptomatic essential hypertension: Its relationship with aldosterone and the increase in sodium-proton exchanger activity
99. Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension
100. Association between circulating components of the renin angiotensin aldosterone system and left ventricular mass
101. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function
102. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure
103. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
104. Fibrosis of the human heart and systemic organs in adrenal adenoma
105. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma
106. Comparison of changes in cardiac structure after treatment in secondary hypertension
107. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma and pheochromocytoma
108. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats
109. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism
110. Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone
111. Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis
112. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
113. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. The Randomized Aldactone Evaluation Study (RALES)
114. The effect of spironolactone on morbidity and mortality in patients with severe heart failure